Tricor: Doesn't Lower Heart Risks for Diabetics
In a recent study known as ACCORD, the drug Tricor, which is taken by many Type 2
Tricor boosts good cholesterol and lowers triglycerides, supposedly lowering heart attack risk. But lead investigator Henry Ginsberg of Columbia University says that in most diabetics with Type 2 disease, it did not reduce the combined number of heart attacks, strokes and deaths.
Douglas Weaver of the Henry Ford Health System in Detroit says the drug is way overused. He says the drugs purpose is to reduce cardiovascular events in people with diabetes, but the trial suggests that it does not do that.
The drug, Tricor, was
Chief cardiologist, Steven Nissen, at the Cleveland Clinic, called the analysis unreliable since the subgroup was too small so the results were not trustworthy. Further research is published in the New England Journal of Medicine.
It sounds like the verdict is still out on whether Tricor will continue to benefit diabetic patients. The wisest choice is always to consult your doctor for the most updated facts regarding your medication and continued treatment.